发明名称 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
摘要 Disclosed are novel piperazinyl-pyrazinone derivatives of formula (I) and methods of making them wherein: m is 1 or 2 n is 0, 1, 2, 3 or 4; R1 is H, alkyl, aryl-alkyl, heteroaryl-alkyl, 2-hydroxyethyl, methoxy-alkyl, alkyoxycarbonyl, aryloxy-alkyl or heteroaryloxy-alkyl; R2 and R3 each independently represent H or CH3; R4 and R5 each independently represent H, halogen, methyl, or together with the ring to which carbon atoms they are attached, form a 1H-quinoxalin-2-one nucleus; and R6 represents aryloxy, heteroaryloxy, arylthio, heteroarylthio, aryl-NH, heteroaryl-NH, aryl, aryl carbonyl, heteroaryl, or heteroarylcarbonyl. Compounds of the type disclosed are useful in the treatment of 5-HT2A receptor related disorders.
申请公布号 NZ537629(A) 申请公布日期 2007.05.31
申请号 NZ20030537629 申请日期 2003.06.25
申请人 BIOVITRUM AB 发明人 NILSSON, BJORN;THOR, MARKUS;CERNERUD, MAGNUS;LUNDSTROM, HELENA
分类号 C07D241/06;A61K31/497;A61K31/519;A61K51/00;A61P3/04;A61P3/10;A61P7/02;A61P9/00;A61P9/10;A61P9/12;A61P11/00;A61P13/02;A61P15/00;A61P21/00;A61P25/00;A61P25/04;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P27/06;A61P43/00;C07D241/18;C07D241/20;C07D241/44;C07D403/04;C07D403/06;C07D403/12;C07D405/06;C07D405/12;C07D409/06;C07D409/12;C07D411/12;C07D413/12;C07D487/04;(IPC1-7):C07D295/033;A61K31/496;C07D241/36 主分类号 C07D241/06
代理机构 代理人
主权项
地址